ISTODAX (Romidepsin) Injection
Description of Istodax (Romidepsin)
Istodax is a prescription medicine used to treat people with a type of cancer called cutaneous T- cell lymphoma (CTCL) or peripheral T-cell lymphoma (PTCL) after at least one other type of medicine by mouth or injection has been tried.
Its use and Indications
Istodax is indicated for the treatment of cutaneous T-cell lymphoma (CTCL) in patients who have received at least one prior systemic therapy.
For treatment related information, please consult your treating Physician.
Istodax is supplied as a kit including which includes a sterile, lyophilized powder in a single-use vial containing 10 mg of Romidepsin and 20 mg of the bulking agent, povidone, USP. In addition, each kit includes one sterile diluent vial containing 2 ml (deliverable volume) of 80% propylene glycol, USP, and 20% dehydrated alcohol, USP
Istodax (Romidepsin) for injection is supplied as a kit containing 2 vials in a single carton.
Storage and handling
The carton must be stored between 15°C to 30°C
Keep out of reach of children
How do we source the Drug?
Super Specialities Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is mandatory, with all relevant documents associated with its procurement is essential.
Company that Manufactures/ Markets:
M/s Celgene Corporation Summit
Mob No: +91 7738100125, +91 7738151650
E Mail: email@example.com